Allied Healthcare (ASX: AHZ) director Peter Turvey has increase his shareholding by 333,333 shares through the exercise of options.
He paid a total consideration of $19,999.98 for the unlisted options that are exercisable at $0.06 and expire on 18 May 2017.
Turvey now has 1,721,997 shares in the company and 666,667 unlisted options.
Shares in the company are currently trading at $0.093.
The company had this week said that patients under its ongoing Phase II extension study for the CardioCel® regenerative tissue repair product showing had shown no signs of calcification after five years.
This represents a key advantage over competing tissue repair products, which typically show signs of calcium build-up at the site of repair within six months post-surgery.
The Allied Healthcare share price has risen over three-fold since mid year.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX "Small and Mid-cap" stocks with distribution in Australia, UK, North America and Hong Kong / China.